Cormorant Asset Management, LP - 31 Jan 2026 SCHEDULE 13G/A Report for Bright Minds Biosciences Inc. Common Shares (DRUG)

Filing Manager: Cormorant Asset Management, LP
Reporting Manager: Cormorant Asset Management, LP
Security: Bright Minds Biosciences Inc. Common Shares
Symbol: DRUG
Shares outstanding: 9,736,498 shares
Disclosed Ownership: 1,059,331 shares
Ownership: 11%
Form type: SCHEDULE 13G/A
Filing time: 06 Feb 2026, 15:00:09 UTC
Date of event: 31 Jan 2026
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Cormorant Asset Management, LP	11%	1,059,331	0	1,059,331	/s/ Bihua Chen	Bihua Chen, Managing Member
Bihua Chen	11%	1,059,331	0	1,059,331	/s/ Bihua Chen	Bihua Chen